A pilot study of the feasibility of empagliflozin in recent-onset type 1 diabetes

INTRODUCTION: Sodium-glucose linked transporter (SGLT) inhibitors could improve glycaemia and simplify insulin regimens in recent-onset type 1 diabetes (T1D), provided they were well-tolerated and safe. This study aimed to determine the feasibility and safety of a SGLT inhibitor for the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wentworth, John M., Fourlanos, Spiros, Colman, Peter G., Harrison, Leonard C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424822/
https://www.ncbi.nlm.nih.gov/pubmed/32812918
http://dx.doi.org/10.1016/j.metop.2020.100021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424822/
https://www.ncbi.nlm.nih.gov/pubmed/32812918
http://dx.doi.org/10.1016/j.metop.2020.100021

Ejemplares similares